Naringenin – a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence
Biomolecules and Biomedicine · 2024
DOI: 10.17305/bb.2024.10511 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Estefania Valle-Velázquez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico; Sección de Estudios de Posgrado e…. Hauptthemen laut MEDLINE: Flavanones, Diabetic Nephropathies. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia, which is a major contributing factor to chronic kidney disease (CKD), end-stage renal disease (ESRD), and cardiovascular-related deaths. There are several mechanisms leading to kidney injury, with hyperglycemia well known to stimulate oxidative stress, inflammation, tissue remodeling, and dysfunction in the vascular system and organs. Increased reactive oxygen species (ROS) decrease the bioavailability of vasodilators while increasing vasoconstrictors, resulting in an imbalance in vascular tone and the development of hypertension. Treatments for diabetes focus on controlling blood glucose levels, but due to the complexity of the disease, multiple drugs are often required to successfully delay the development of microvascular complications, including CKD. In this context, naringenin, a flavonoid found in citrus fruits, has demonstrated anti-inflammatory, anti-fibrotic, and antioxidant effects, suggesting its potential to protect the kidney from deleterious effects of diabetes. This review aims to summarize the scientific evidence of the effects of naringenin as a potential therapeutic option for diabetes-induced CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico; Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Na…
- Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.
Zitieren
APA
Valle-Velázquez, E., Zambrano-Vásquez, O. R., Cortés-Camacho, F., Sánchez-Lozada, L. G., Guevara-Balcázar, G., & Osorio-Alonso, H. (2024). Naringenin – a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10511
Vancouver
Valle-Velázquez E, Zambrano-Vásquez OR, Cortés-Camacho F, Sánchez-Lozada LG, Guevara-Balcázar G, Osorio-Alonso H. Naringenin – a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10511
BibTeX
@article{ValleVelzquez2024,
author = {Valle-Velázquez, Estefania and Zambrano-Vásquez, Oscar René and Cortés-Camacho, Fernando and Sánchez-Lozada, Laura Gabriela and Guevara-Balcázar, Gustavo and Osorio-Alonso, Horacio},
title = {Naringenin – a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence},
journal = {Biomolecules and Biomedicine},
year = {2024},
doi = {10.17305/bb.2024.10511}
}
EUVIMED